Supply Notice – Salofalk (mesalazine) 500mg and 1g suppositories

Supply Notice – Salofalk (mesalazine) 500mg and 1g suppositories

November 1, 2019

Ref: MSN/2019/003
Tier 2 – medium impact
Date of issue 1 November 2019

Further to the recent shortage notice regarding Salofalk, the Department of Health and Social Care have today provided the following update.

Summary

  • Salofalk® 500mg suppositories are out of stock until w/c 16th December 2019.
  • Salofalk® 1g suppositories will be out of stock from late November until w/c 16th December 2019.
  • Pentasa® (mesalazine) 1g suppositories remain available during this period.

Actions Required

  • For patients without sufficient supplies of Salofalk® suppositories to last until the resolution date, prescribers may consider switching to Pentasa®
  • The below table can be used to support dose conversion between brands:
Salofalk®: Existing regimen Pentasa®: Proposed regimen
1g daily 1g daily
500mg twice daily 1 g daily
500mg three times daily Either 1 g daily (within licence) or 1g twice daily (off label)
2 x 500mg suppositories twice daily 1g twice daily (off label)
2 x 500mg suppositories three times daily 1g three times daily (off label)
  • Clinicians (both prescribing and dispensing) should counsel patients regarding the different dosing regimen prescribed, where appropriate.

Supporting Information

Enquiries

If you have any queries, please contact DHSCmedicinesupplyteam@dhsc.gov.uk

For more information on medicines shortages, click here.

To report a medicine shortage, click here.



Posted in: ,


More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...